SeoulMarkets · tag
rights issue
3 stories tagged “rights issue”, each from official Korean data with its source and timestamp.
EcoPro BM's ₩886bn raise: 100% for an unnamed acquisition
EcoPro BM's rights issue creates 9,900,990 new shares at ₩89,500 — a 16% discount to the ₩106,500 close — diluting existing holders 9.2%. All ₩886.1bn raised is filed as 'business acquisition'; no target has been separately disclosed.
From Celltrion to KG Mobility, one flaw repeats
This week we ranked 35 Korean capital-raising filings three ways — buybacks, rights issues, convertible bonds. In every single one, the size of the deal did not predict what it meant for existing shareholders.
Samsung Biologics raised 300x more, diluted 11x less
Samsung Biologics' ₩3.00tn rights issue diluted shareholders 4.7%. PhionX raised 300 times less — and diluted 53.8%, eleven times more. Twenty-one filings this week show size doesn't predict dilution.